(Q38078278)

28 August 2017

1 reference

title

Antiretroviral therapy for prevention is a combination strategy (English)

1 reference

28 August 2017

main subject

anti-retroviral agent

0 references

2

Myron Cohen

1 reference

28 August 2017

3

Wafaa M El-Sadr

1 reference

28 August 2017

1

Margaret L McNairy

1 reference

28 August 2017

publication date

1 June 2013

1 reference

28 August 2017

published in

Current HIV/AIDS reports

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

152-158

1 reference

HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

HIV prevention before HAART in sub-Saharan Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

The first decade of antiretroviral therapy in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Projected life expectancy of people with HIV according to timing of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

High acceptance of home-based HIV counseling and testing in an urban community setting in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

High accuracy of home-based community rapid HIV testing in rural Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

High uptake of home-based, district-wide, HIV counseling and testing in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Uptake of provider-initiated HIV testing and counseling among women attending an urban sexually transmitted disease clinic in South Africa - missed opportunities for early diagnosis of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Linkage and retention in HIV care among men who have sex with men in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

The therapeutic implications of timely linkage and early retention in HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Delayed initiation of antiretroviral therapy among HIV-discordant couples in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

HIV incidence in young girls in KwaZulu-Natal, South Africa--public health imperative for their inclusion in HIV biomedical intervention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Antiretroviral treatment as prevention: impact of the 'test and treat' strategy on the tuberculosis epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Linking HIV prevention and care for community interventions among high-risk women in Burkina Faso--the ARNS 1222 "Yerelon" cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-013-0152-1

Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention

21 January 2018

1 reference

12 December 2020

Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006.

1 reference

12 December 2020

Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008

1 reference

12 December 2020

Universal voluntary testing and treatment for prevention of HIV transmission

1 reference

12 December 2020

The HIV care continuum: no partial credit given

1 reference

12 December 2020

HIV prevalence among high school learners - opportunities for school-based HIV testing programmes and sexual reproductive health services.

1 reference

12 December 2020

Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.

1 reference

12 December 2020

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings

1 reference

12 December 2020

Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.

1 reference

12 December 2020

Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV.

1 reference

12 December 2020

Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count

1 reference

12 December 2020

Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men

1 reference

12 December 2020

10.1007/S11904-013-0152-1

Identifiers

DOI

1 reference

28 August 2017

1 reference